-
Spalletti bidding to revive Juve and reputation ahead of Sporting visit in Champions League
-
Tanzania president to be inaugurated as opposition says hundreds dead
-
Bouanga brace as LAFC beats Austin 4-1 to advance in MLS Cup playoffs
-
'Golden age': Japan hails Yamamoto, Ohtani after Dodgers triumph
-
Thunder roll over Pelicans to remain NBA's lone unbeaten team
-
Hong Kong legislature now an 'echo chamber', four years after shake-up
-
Most Asian markets rise on lingering trader optimism
-
Andrew to lose his last military rank: defence minister
-
Trump's global tariffs to face challenge before Supreme Court
-
Barnstorming Bayern face acid test at reigning champions PSG
-
Alonso shaping new Real Madrid on Liverpool return
-
Half Yours favourite at Australia's 'race that stops a nation'
-
Tonga rugby league star has surgery after 'seizure' against NZ
-
Trent's return with Real Madrid reminds Liverpool of what they are missing
-
Tehran toy museum brings old childhood memories to life
-
Iran banking on Iraq vote to retain regional influence
-
Daughter of 'underground' pastor urges China for his release
-
Trump the Great? President steps up power moves
-
Fire ravages French monastery dubbed 'Notre-Dame of the Ardennes'
-
Bills outlast Chiefs while NFL-best Colts fall to Steelers
-
NBA champion Thunder roll over Pelicans to remain unbeaten
-
Eliud Kipchoge unveils plan to run 7 marathons on 7 continents
-
Milan deny Roma top spot in Serie A, Inter beat Verona
-
Lens back up to third in Ligue 1 as Lyon held at Brest
-
NFL-best Colts fall to Steelers, Packers lose to Carolina
-
'Regretting You' wins spooky slow N. American box office
-
'Just the beginning' as India lift first Women's World Cup
-
Will Still sacked by struggling Southampton
-
Malinin wins Skate Canada crown with stunning free skate
-
Barca beat Elche to recover from Clasico loss
-
Jamaica deaths at 28 as Caribbean reels from colossal hurricane
-
Verma and Sharma power India to first Women's World Cup triumph
-
Auger-Aliassime out of Metz Open despite not yet securing ATP Finals spot
-
Haaland fires Man City up to second in Premier League
-
Sinner says staying world number one 'not only in my hands'
-
Ready for it? Swifties swarm German museum to see Ophelia painting
-
Pope denounces violence in Sudan, renews call for ceasefire
-
Kipruto, Obiri seal Kenyan double at New York Marathon
-
OPEC+ further hikes oil output
-
Sinner returns to world number one with Paris Masters win
-
Sinner wins Paris Masters, reclaims world No. 1 ranking
-
Nuno celebrates first win as West Ham boss
-
Obiri powers to New York Marathon win
-
Two Louvre heist suspects a couple with children: prosecutor
-
Verma, Sharma help India post 298-7 in Women's World Cup final
-
Inter snapping at Napoli's heels, Roma poised to pounce
-
India space agency launches its heaviest satellite
-
Wolves sack Pereira after winless Premier League start
-
Debutants Berkane among CAF Champions League top seeds
-
Sundar steers India to five-wicket win over Australia in 3rd T20
US greenlights pig kidney transplant trials
Two US biotech companies say the Food and Drug Administration has cleared them to conduct clinical trials of their gene-edited pig kidneys for human transplants.
United Therapeutics along with another company, eGenesis, have been working since 2021 on experiments implanting pig kidneys into humans: initially brain-dead patients and more recently living recipients.
Advocates hope the approach will help address the severe organ shortage. More than 100,000 people in the United States are awaiting transplants, including over 90,000 in need of kidneys.
United Therapeutics's approval, announced Monday, allows the company to advance its technology toward a licensed product if the trial succeeds.
The study authorization was hailed as a "significant step forward in our relentless mission to expand the availability of transplantable organs," by Leigh Peterson, the company's executive vice president.
The trial will initially enroll six patients with end-stage renal disease before expanding to as many as 50, United Therapeutics said in a statement. The first transplant is expected in mid-2025.
Meanwhile, rival eGenesis said it had received FDA approval in December for a separate three-patient kidney study.
"The study will evaluate patients with kidney failure who are listed for a transplant but who face a low probability of receiving a deceased donor offer within a five-year timeframe," the company said.
Xenotransplantation -- transplanting organs from one species to another -- has been a tantalizing yet elusive goal for science.
Early experiments in primates faltered, but advances in gene editing and immune system management have brought the field closer to reality.
Pigs have emerged as ideal donors: they grow quickly, produce large litters, and are already part of the human food supply.
United Therapeutics said trial patients would be monitored for life, assessing survival rates, kidney function, and the risk of zoonotic infections -- diseases that jump from animals to humans.
Currently, there is only one living human recipient of a pig organ: Towana Looney, a 53-year-old from Alabama who received a United Therapeutics kidney on November 25, 2024.
She is also the longest-surviving recipient, having lived with a pig kidney for 71 days as of Tuesday. David Bennett of Maryland received a pig heart in 2022 and survived 60 days.
G.AbuGhazaleh--SF-PST